interim

SANY Reports Strong First Half 2025 Results, Delivering Profitable Growth

Revenue Up 15% to $6.24 Billion; Operating Cash Flow Up 20% to $1.42 Billion SHANGHAI, Aug. 28, 2025 /PRNewswire/ --…

4 days ago

ZETADISPLAY AB (publ) INTERIM REPORT 1 APRIL 30 JUNE 2025 (Q2)

Q2 Interim report April – June 2025 for ZetaDisplay AB (publ) is now published at the ZetaDisplay Investor relations web:…

6 days ago

Angelalign Technology Announces First-Half 2025 Results While Increasing Investments in Legal, Supply Chain and Data Security

SAN CLEMENTE, Calif., Aug. 26, 2025 /PRNewswire/ -- Angelalign Technology Inc. ("Angel" or the "Company") (6699.HK) announced its interim results…

1 week ago

Interim report H1 2025

9% organic sales growth in H1 and FY outlook range narrowed to 6-8% Ester Baiget, President & CEO: “I’m very…

2 weeks ago

41/2025Trifork Group: Interim report for the quarter and half-year ending 30 June 2025

Company announcement no. 41/2025Schindellegi, Switzerland – 19 August 2025 Interim Financial Report for the three and six months ending 30…

2 weeks ago

ADNOC Gas Announces Record Second Quarter Performance, Demonstrating Resilience in Lower Price Environment

Highest-ever quarterly net income of $1.385 billion, up 16% YoY, reflects the Company's strong performance Board approves interim dividend of…

4 weeks ago

Sonata Software Q1 FY26 Consolidated PAT Grew 1.7% QoQ, And Announces First Interim Dividend of Rupees 1.25 Per Share

MUMBAI, India, July 30, 2025 /PRNewswire/ -- Sonata Software (NSE: SONATSOFTW) (BSE: 532221), a leading Modernization Engineering Company, today reported…

1 month ago

Emerald Clinical Trials Confirms CEO Transition and Continuity Plan

SINGAPORE, July 30, 2025 /PRNewswire/ -- Emerald Clinical Trials, a leading global clinical research organization, today announced a leadership transition.…

1 month ago

Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop

– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel long-acting herpes simplex virus helicase-primase…

1 month ago

HUTCHMED to Announce 2025 Half-Year Financial Results

July 03, 2025 04:30 ET  | Source: HUTCHMED (China) Limited HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 03,…

2 months ago